The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

Weight loss is quick, easy, fleeting, and unhealthy. Fat loss is challenging and long term, but it lasts and promotes your ...

A 4:3 nonconsecutive intermittent fasting regimen was more tolerable and yielded somewhat greater weight loss at 1 year than ...

Linda Bethea details how the marketer of brands including Oikos and Silk is approaching artificial intelligence and emerging ...

Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...

For weight loss to be effective, we must consider the diverse factors contributing to weight gain, which vary from person to ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Contacted by TODAY.com, a spokesperson for Oz did not provide comment on the lawsuit, his claims about weight loss supplements, or how they may affect his work as head of CMS, if confirmed, and ...

The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...

In the corners of social media dominated by wellness content, influencers recommend an assortment of treatments and products ...

Disney, which is staying in business with the NBA even as it sheds some of the games it previously showed, is seen capturing $1.25 billion in annual ad revenue from NBA games, according to Fishman ...